Angus McQuilken, the Vice President for Communications and Marketing joined NECN on August 21, 2015 to discuss the Clinical Innovation Gateway and the scientific return on investment from the MLSC’s capital grant to Joslin Diabetes Center.
Angus McQuilken, the Vice President for Communications and Marketing joined NECN on August 21, 2015 to discuss the Clinical Innovation Gateway and the scientific return on investment from the MLSC’s capital grant to Joslin Diabetes Center.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.